Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Guler

Showing results (21-30 of 90) with videos related to

Pageof 9
Sort By:
Genetic Counseling (Geneva, Switzerland)|December 3, 2015
CEREBRAL VENOUS THROMBOSIS AND TURNER SYNDROME: A RARE REPORTED ASSOCIATIONA Guler, S Alpaydin, F Bademkiran, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|July 21, 2016
A case with hyperammonemic encephalopathy triggered by single dose valproateS Ciftci, A Guler, E Deveci, et al.
Cardiovascular Journal of Africa|December 14, 2011
A rare complication after coronary artery bypass graft surgery: Ogilvie's syndromeA Guler, M A Sahin, K Atilgan, et al.
Perfusion|November 28, 2013
Complete A-V block: incidental or a part of cor triatriatum dexterY Guler, T Akgun, C Toprak, et al.
American Journal of Respiratory and Critical Care Medicine|January 15, 2021
What Is Idiopathic Pulmonary Fibrosis? IPF Part 1Sabina A Guler, Kathleen O Lindell, Jeff Swigris, et al.
Respiratory Medicine|December 30, 2024
Pulmonary rehabilitation and functional independence: Impact on survival in patients with fibrotic interstitial lung disease or chronic obstructive pulmonary diseaseAnnina Elmiger, Thimo Marcin, Luc Bovet, et al.
American Journal of Respiratory and Critical Care Medicine|February 1, 2021
Medications for Idiopathic Pulmonary Fibrosis: IPF Part 2Sabina A Guler, Kathleen O Lindell, Jeff Swigris, et al.
Current Opinion in Pulmonary Medicine|June 11, 2026
Oxygen therapy in interstitial lung disease - navigating benefit and burdenSabina A Guler, Yet H Khor, Anne E Holland, et al.
American Journal of Respiratory and Critical Care Medicine|February 12, 2021
Nondrug Treatments for Idiopathic Pulmonary Fibrosis: IPF Part 3Sabina A Guler, Kathleen O Lindell, Jeff Swigris, et al.
Journal of Endocrinological Investigation|September 6, 2019
Elevated circulating levels of secreted frizzled-related protein 4 in relation to insulin resistance and androgens in women with polycystic ovary syndromeM Bicer, P Alarslan, A Guler, et al.
Pageof 9

Showing results (21-30 of 90) with videos related to

Sort By:
Pageof 9
Genetic Counseling (Geneva, Switzerland)|December 3, 2015
CEREBRAL VENOUS THROMBOSIS AND TURNER SYNDROME: A RARE REPORTED ASSOCIATIONA Guler, S Alpaydin, F Bademkiran, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|July 21, 2016
A case with hyperammonemic encephalopathy triggered by single dose valproateS Ciftci, A Guler, E Deveci, et al.
Cardiovascular Journal of Africa|December 14, 2011
A rare complication after coronary artery bypass graft surgery: Ogilvie's syndromeA Guler, M A Sahin, K Atilgan, et al.
Perfusion|November 28, 2013
Complete A-V block: incidental or a part of cor triatriatum dexterY Guler, T Akgun, C Toprak, et al.
American Journal of Respiratory and Critical Care Medicine|January 15, 2021
What Is Idiopathic Pulmonary Fibrosis? IPF Part 1Sabina A Guler, Kathleen O Lindell, Jeff Swigris, et al.
Respiratory Medicine|December 30, 2024
Pulmonary rehabilitation and functional independence: Impact on survival in patients with fibrotic interstitial lung disease or chronic obstructive pulmonary diseaseAnnina Elmiger, Thimo Marcin, Luc Bovet, et al.
American Journal of Respiratory and Critical Care Medicine|February 1, 2021
Medications for Idiopathic Pulmonary Fibrosis: IPF Part 2Sabina A Guler, Kathleen O Lindell, Jeff Swigris, et al.
Current Opinion in Pulmonary Medicine|June 11, 2026
Oxygen therapy in interstitial lung disease - navigating benefit and burdenSabina A Guler, Yet H Khor, Anne E Holland, et al.
American Journal of Respiratory and Critical Care Medicine|February 12, 2021
Nondrug Treatments for Idiopathic Pulmonary Fibrosis: IPF Part 3Sabina A Guler, Kathleen O Lindell, Jeff Swigris, et al.
Journal of Endocrinological Investigation|September 6, 2019
Elevated circulating levels of secreted frizzled-related protein 4 in relation to insulin resistance and androgens in women with polycystic ovary syndromeM Bicer, P Alarslan, A Guler, et al.
Pageof 9